Search

… ProQR to Host R&D Day in New York on January 29 LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & … ET at the Lotte New York Palace Hotel in New York, NY. The R&D day will feature presentations by internal ProQR and …

… ProQR to Present at the H.C. Wainwright Global Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …

… ProQR to Participate in the Cantor Virtual Rare Orphan … & CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … in Rare Diseases panel from 2:45-3:45pm EDT. About ProQR ProQR Therapeutics is dedicated to changing lives …

… ProQR Appoints David M. Rodman, MD as Chief Development … the Netherlands, March 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that it … of RNA approaches to treating disease.” said Noreen R. Henig, MD, Chief Medical Officer. “There are very few …

… ProQR Announces Clinical Data Presentations and Investor & … the Netherlands, Sept. 27, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … 27 Noreen Henig, M.D., Chief Development Officer of ProQR and John P. Clancy, M.D., principal investigator, …

… ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory … LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … codons,” said Daniel de Boer, chief executive officer of ProQR. "We welcome Dr. Yu to our scientific advisory board, …

… ProQR Receives Rare Pediatric Disease Designation from FDA … & CAMBRIDGE, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel A. de Boer, chief executive officer of ProQR. “Both sepofarsen for LCA10, the most common cause of …

… ProQR Announces Presentations on Programs in Ophthalmology at … LEIDEN, the Netherlands, July 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … II       Presentation at OIS Retina Daniel de Boer, CEO of ProQR, will give a presentation highlighting the company’s …

… ProQR Announces Presentations at the European Oligonucleotide … and CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to …         Peter Adamson, PhD, SVP Ophthalmology Science of ProQR Presentation :     Thursday, November 8 at 14:15 - …

… ProQR Achieves Successful Defense of New Challenge to its … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … the European Patent Office (EPO) by a strawman against ProQR’s granted patent EP 3 507 366 B1 , which relates to …